Lebecque P - Search Results

1

Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients.

Melotti P, Mafficini A, Lebecque P, Ortombina M, Leal T, Pintani E, Pepermans X, Sorio C, Assael BM. Melotti P, et al. Among authors: lebecque p. PLoS One. 2014 Dec 12;9(12):e114274. doi: 10.1371/journal.pone.0114274. eCollection 2014. PLoS One. 2014. PMID: 25503271 Free PMC article.

2

Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis.

Mafficini A, Ortombina M, Sermet-Gaudelius I, Lebecque P, Leal T, Iansa P, Reychler G, Dahan K, Pepermans X, Lenoir G, Leonard A, Sorio C, Assael B, Melotti P. Mafficini A, et al. Among authors: lebecque p. J Cyst Fibros. 2011 Jul;10(4):228-33. doi: 10.1016/j.jcf.2010.10.007. Epub 2011 Mar 24. J Cyst Fibros. 2011. PMID: 21435954 Free article.

3

Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children.

Lebecque P, Leal T, De Boeck C, Jaspers M, Cuppens H, Cassiman JJ. Lebecque P, et al. Am J Respir Crit Care Med. 2002 Mar 15;165(6):757-61. doi: 10.1164/ajrccm.165.6.2104073. Am J Respir Crit Care Med. 2002. PMID: 11897640

4

Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.

Lebecque P, Leal T, Zylberberg K, Reychler G, Bossuyt X, Godding V. Lebecque P, et al. J Cyst Fibros. 2006 Dec;5(4):237-44. doi: 10.1016/j.jcf.2006.04.001. Epub 2006 Jun 21. J Cyst Fibros. 2006. PMID: 16790367 Free article.

5

Airway ion transport impacts on disease presentation and severity in cystic fibrosis.

Leal T, Fajac I, Wallace HL, Lebecque P, Lebacq J, Hubert D, Dall'Ava J, Dusser D, Ganesan AP, Knoop C, Cumps J, Wallemacq P, Southern KW. Leal T, et al. Among authors: lebecque p. Clin Biochem. 2008 Jul;41(10-11):764-72. doi: 10.1016/j.clinbiochem.2008.03.013. Epub 2008 Apr 8. Clin Biochem. 2008. PMID: 18424267

6

Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.

Meyer M, Huaux F, Gavilanes X, van den Brûle S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T. Meyer M, et al. Among authors: lebecque p. Am J Respir Cell Mol Biol. 2009 Nov;41(5):590-602. doi: 10.1165/rcmb.2008-0155OC. Epub 2009 Feb 24. Am J Respir Cell Mol Biol. 2009. PMID: 19244203

7

Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice.

Lubamba B, Lebacq J, Lebecque P, Vanbever R, Leonard A, Wallemacq P, Leal T. Lubamba B, et al. Among authors: lebecque p. Am J Respir Crit Care Med. 2009 Jun 1;179(11):1022-8. doi: 10.1164/rccm.200901-0049OC. Epub 2009 Mar 19. Am J Respir Crit Care Med. 2009. PMID: 19299496

8

A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference.

Leonard A, Lebecque P, Dingemanse J, Leal T. Leonard A, et al. Among authors: lebecque p. J Cyst Fibros. 2012 May;11(3):231-6. doi: 10.1016/j.jcf.2011.12.004. Epub 2012 Jan 27. J Cyst Fibros. 2012. PMID: 22281182 Free article. Clinical Trial.

9

Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis.

Huaux F, Noel S, Dhooghe B, Panin N, Lo Re S, Lison D, Wallemacq P, Marbaix E, Scholte BJ, Lebecque P, Leal T. Huaux F, et al. Among authors: lebecque p. PLoS One. 2013 May 29;8(5):e64341. doi: 10.1371/journal.pone.0064341. Print 2013. PLoS One. 2013. PMID: 23734196 Free PMC article.

10

[Cystic fibrosis and normal sweat chloride values: a case-report].

Lebecque P, Leal T, Godding V. Lebecque P, et al. Rev Mal Respir. 2001 Sep;18(4 Pt 1):443-5. Rev Mal Respir. 2001. PMID: 11547256 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters